![Neurochirurgická ambulance - Fakultní nemocnice Hradec Králové (Hradec Králové, Nový Hradec Králové) • Firmy.cz Neurochirurgická ambulance - Fakultní nemocnice Hradec Králové (Hradec Králové, Nový Hradec Králové) • Firmy.cz](https://d48-a.sdn.cz/d_48/c_img_H_D/45Z5WU.jpeg?fl=res,600,400,3,ffffff)
Neurochirurgická ambulance - Fakultní nemocnice Hradec Králové (Hradec Králové, Nový Hradec Králové) • Firmy.cz
![Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry - Annals of Oncology Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/9a8d6f8d-8b85-45e3-a86b-0658775b46bd/gr1_lrg.jpg)
Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry - Annals of Oncology
![Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database | SpringerLink Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12032-012-0286-9/MediaObjects/12032_2012_286_Fig1_HTML.gif)
Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database | SpringerLink
![Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database | SpringerLink Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12032-012-0286-9/MediaObjects/12032_2012_286_Fig3_HTML.gif)
Patients with advanced and metastatic renal cell carcinoma treated with targeted therapy in the Czech Republic: twenty cancer centres, six agents, one database | SpringerLink
![Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry - Annals of Oncology Sunitinib followed by sorafenib or vice versa for metastatic renal cell carcinoma—data from the Czech registry - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/03ea64b3-8bc1-4956-a1fb-634144317b3c/gr1.jpg)